flestolol has been researched along with Auricular Fibrillation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burge, J; Katz, RJ; Keefe, D; Laddu, AR; Somberg, JC; Steinberg, JS | 1 |
| Liem, LB; Peterson, J; Swerdlow, CD | 1 |
1 trial(s) available for flestolol and Auricular Fibrillation
| Article | Year |
|---|---|
Safety and efficacy of flestolol, a new ultrashort-acting beta-adrenergic blocking agent, for supraventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Clinical Trials as Topic; Female; Fluorobenzenes; Half-Life; Humans; Hypotension; Male; Middle Aged; Myocardial Contraction; Propanolamines; Time Factors | 1986 |
1 other study(ies) available for flestolol and Auricular Fibrillation
| Article | Year |
|---|---|
Effect of flestolol on ventricular rate during atrial fibrillation in Wolff-Parkinson-White syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Atrial Fibrillation; Cardiac Pacing, Artificial; Drug Therapy, Combination; Electrocardiography; Female; Fluorobenzenes; Humans; Isoproterenol; Male; Middle Aged; Propanolamines; Wolff-Parkinson-White Syndrome | 1988 |